PD-L1 Antibody FITC
Catalog no. PDL1-FITC · Research Use Only
$375 per 100 µg. Ships within 2–3 business days from the U.S.
PDL1-FITC — affinity purified Rabbit antibody against PD-L1. Validated for ELISA, IHC, IP, WB. Reacts with Human, Monkey, Mouse, Rat.
Specifications
| Catalog number | PDL1-FITC |
|---|---|
| Target | PD-L1 |
| Host | Rabbit |
| Clonality | Polyclonal |
| Isotype | IgG |
| Reactivity | Human, Monkey, Mouse, Rat |
| Applications | ELISA, IHC, IP, WB |
| Conjugate | FITC |
| Purity | Affinity Purified |
| Immunogen | Synthetic peptide taken within amino acid reigon 80-130 on human Progammed cell death 1 ligand 1 protein. |
| Size | 100 µg |
| Storage | -20°C |
| UniProt | Q9NZQ7 |
About this target
PD-L1 Antibody FITC (PDL1-FITC) is the fluorescein-conjugated version of the FabGennix PD-L1 rabbit polyclonal antibody (PDL1-101AP). The FITC label allows direct fluorescent detection without a secondary antibody. The unconjugated antibody is listed as PDL1-101AP. Involved in the costimulatory signal, essential for T-cell proliferation and production of IL10 and IFNG, in an IL2-dependent and a PDCD1-independent manner. Interaction with PDCD1 inhibits T-cell proliferation and cytokine production. Belongs to the immunoglobulin superfamily. BTN/MOG family. Contains 1 Ig-like C2-type (immunoglobulin-like) domain. Contains 1 Ig-like V-type (immunoglobulin-like) domain. Subcellular location: Isoform 1 : Cell membrane; Single-pass type I membrane protein Isoform 2 : Endomembrane system; Single-pass type I membrane protein. Expression: Highly expressed in the heart, skeletal muscle, placenta and lung. Weakly expressed in the thymus, spleen, kidney and liver. Expressed on activated T- and B-cells, dendritic cells, keratinocytes and monocytes.
Documents
Related products
- PD-L1 Blocking Peptide (P-PDL1)
- PD-L1 Positive Control (PC-PDL1)
- PD-L1 Antibody (PDL1-101AP)
- PD-L1 Antibody BIOTIN (PDL1-BIOTIN)
FabGennix International, Inc., 9191 Kyser Way, Frisco, TX 75033. For research use only. Not for diagnostic or therapeutic use.